Loading insider details...
Latest Form 4 (Jun 11, 2026): Disposition to Issuer of 14,000 KALV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 14,000 | n/a |
| Oct 2, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 30,000 | n/a |
| Oct 4, 2024 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 10,000 | n/a |
| Sep 28, 2023 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 10,000 | n/a |
| Oct 17, 2022 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 10,000 | n/a |
| Mar 19, 2021 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 14,000 | n/a |